Sabah Akbarali Khawaja is a Houston, Texas based nurse practitioner. Active license number of Sabah Akbarali Khawaja is 1113463 for Acute Care in Texas. Her current practice location is 7200 Cambridge St Ste 9b, Houston. Patients can reach her at 713-798-4951 and her NPI number (Unique professional ID assigned by NPPES) is 1245947811. Sabah Akbarali Khawaja has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Sabah Akbarali Khawaja speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1245947811
NPI Enumeration Date:
02 Nov, 2022
NPI Last Update On:
15 Sep, 2023
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Sabah Akbarali Khawaja are as mentioned below.
License Number
Specialization
State
Status
1113463
Acute Care
Texas
Primary
1113463
Nurse Practitioner
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Sabah Akbarali Khawaja 1906 Thomas Smith Ct, Richmond, Texas
Zip:
77469-4751
Patients can reach Sabah Akbarali Khawaja at 7200 Cambridge St Ste 9b, Houston, Texas or can call to book an appointment on 713-798-4951.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.